Thrombolytic therapy and the new environment of medical practice.
D003362:Cost-Benefit Analysis; D006801:Humans; D009203:Myocardial Infarction / Q000191:economics*; D010960:Plasminogen Activators / Q000627:therapeutic use*; D013300:Streptokinase / Q000627:therapeutic use*
D013300:Streptokinase; D010960:Plasminogen Activators